JAK2/STAT3 signalling pathway activation by melatonin during diabetic nephropathy was also demonstrated by Ji and colleagues that confirmed decrease in apoptotic podocyte number, down‐regulation in Bax level, reduction in oxidative stress damage and alleviation in inflammation after melatonin treatment.22 This evidence concerns the gene BAX and diabetic kidney disease.